HomeTagsSGX

SGX

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Inside Jadason Enterprises $2.5 Million Turnaround In FY2025

https://open.spotify.com/episode/3T96SDEr00y72J4HBRD4SV?si=7dcd01a939734673 Introduction: The Art of the Corporate Comeback Steering a company from a deep operational loss...
SGX-LISTED COMPANIES

How City Developments Tripled Profits In FY2025

https://open.spotify.com/episode/1QIw0KqIt9MndVfBDgJ9bq?si=ab425a905ba54eb7 The Asset-Light Coup: Inside CDL’s $2 Billion Capital Recycling Masterclass The 2025 fiscal landscape was...
SGX-LISTED COMPANIES

How Olam Group Re-Engineered Its Future With A 414% Profit Pivot In FY2025

https://open.spotify.com/episode/0kbI1OqIaESizNrTLHvcMP?si=8f1c0cd5aef5490e In the high-stakes theater of global commodities, 2025 was a year characterized by what...
SGX-LISTED COMPANIES

How Soilbuild Construction Achieved A Record-Breaking FY2025

https://open.spotify.com/episode/021GTljObhZ0e7ptaKUcaJ?si=86dae7a57d8e4743 Beyond Bricks and Mortar: 5 Takeaways from Soilbuild’s Record-Breaking Year The 50-Year "Overnight Success" In the...
SGX-LISTED COMPANIES

SUTL Enterprise Just Bought This Iconic Singapore Marina In FY2025

https://open.spotify.com/episode/7I5kOv9opzN4Mpb434LBKU?si=8eec96911e7a4de3 Charting a New Course: 4 Key Takeaways from SUTL Enterprise’s Bold FY2025 Growth Strategy Standing...
SGX-LISTED COMPANIES

Seatrium FY2025 Profits Double via Series Build Strategy

https://open.spotify.com/episode/4WSi7kfwIf0k3vqXAcI9vf?si=c5d5d5af831745db The $11.5 Billion Turnaround: 5 Surprising Takeaways from Seatrium’s Record-Breaking 2025 Industrial mega-mergers are notoriously...
SGX-LISTED COMPANIES

Megachem Bets On A High-Stake Specialty Chemical Rebuild In FY2025

https://open.spotify.com/episode/4RUoJWaAKJMC4kvDctm92g?si=a6b16fb33aba44fa From Ashes to Assets On July 5, 2023, a massive fire at Megachem’s facilities served...
SGX-LISTED COMPANIES

ABR Holdings Makes A $427 Million Pivot In FY2025

https://open.spotify.com/episode/0ETGmmjTvjwcdR3IXscy7U?si=ff4f99c684184cc3 From Sundaes to Skyscrapers: Can ABR Group’s $427 Million Pivot Hedge Against a Squeezed...
SGX-LISTED COMPANIES

Singapore Land’s Massive FY2025 Sydney Move

https://open.spotify.com/episode/6f08AonwL5YmfCa6dad1mS?si=89f0a8a1e4194aea To the casual observer, Singapore Land Group Limited’s (SingLand) FY2025 results present a riddle....
SGX-LISTED COMPANIES

Sing Holdings Bags Over 1000% Profit In FY2025

https://open.spotify.com/episode/4kMuadqKhQ9EoAGWizU6v8?si=d1d98a0862ae44e5 From Milestone to Masterplan: 5 Impactful Lessons from Sing Holdings’ Record-Breaking Year The $142 Million...
SGX-LISTED COMPANIES

Is Multi-Chem The Next Big Tech Play? – FY2025

https://open.spotify.com/episode/6bsUdttNHw2Cmt7zvBx2mx?si=5e9cdf1ae09c4cc0 5 Surprising Takeaways from Multi-Chem’s 2025 Shift Introduction: To the casual observer, the name "Multi-Chem Limited"...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...